Patients at Owensboro Health will have easier access to clinical research studies through the hospital's new partnership with the University of Kentucky Markey Cancer Center.
Markey Cancer Center is a National Cancer Institute-designated cancer center, which will open the hospital to up NCI-led trials in addition to other trials in Markey's research network. "Cancer care is constantly improving, due in part to the groundbreaking work being done in clinical research," Dr. Tim Mullett, medical director of the research network, said in a news release.
"Our state has some of the worst cancer incidence and survival rates in the entire country, and we at Markey have an obligation to address this devastating disease. By increasing access to many of our current clinical trials through the Markey Cancer Center Research Network, we have an opportunity to make real progress in improving cancer statistics in Kentucky."
Owensboro Health is now one of six research sites in the network, and the first in Western Kentucky. The hospital's Mitchell Memorial Cancer Center sees more than 1,000 cancer patients annually and serves nearly 400,000 people from 14 counties in Western Kentucky and Southern Indiana.
The research will include "epidemiology, prevention and early detection of cancer," and will target cancers with the highest incidence and mortality rates in Kentucky, including lung, colorectal and cervical cancers, the hospital said.
"Clinical trials represent the latest, best treatment options for most patients, and being able to participate in major national and regional clinical trials right here in Owensboro means that patients are able to stay closer to their own support systems at home and under the direct care of their doctors here," Dr. Mark Evers, director of the UK Markey Cancer Center, said in the release.
The network also includes Hardin Memorial Hospital, Elizabethtown; King's Daughters Medical Center, Ashland; St. Claire Regional Medical Center, Morehead; Tri-State Regional Cancer Center, Ashland; and St. Mary's Regional Cancer Center, Huntington, W.Va.
Markey Cancer Center is a National Cancer Institute-designated cancer center, which will open the hospital to up NCI-led trials in addition to other trials in Markey's research network. "Cancer care is constantly improving, due in part to the groundbreaking work being done in clinical research," Dr. Tim Mullett, medical director of the research network, said in a news release.
"Our state has some of the worst cancer incidence and survival rates in the entire country, and we at Markey have an obligation to address this devastating disease. By increasing access to many of our current clinical trials through the Markey Cancer Center Research Network, we have an opportunity to make real progress in improving cancer statistics in Kentucky."
The research will include "epidemiology, prevention and early detection of cancer," and will target cancers with the highest incidence and mortality rates in Kentucky, including lung, colorectal and cervical cancers, the hospital said.
"Clinical trials represent the latest, best treatment options for most patients, and being able to participate in major national and regional clinical trials right here in Owensboro means that patients are able to stay closer to their own support systems at home and under the direct care of their doctors here," Dr. Mark Evers, director of the UK Markey Cancer Center, said in the release.
The network also includes Hardin Memorial Hospital, Elizabethtown; King's Daughters Medical Center, Ashland; St. Claire Regional Medical Center, Morehead; Tri-State Regional Cancer Center, Ashland; and St. Mary's Regional Cancer Center, Huntington, W.Va.
No comments:
Post a Comment